Dr. Reddys Labs (NYSE: RDY) reported Q3 EPS of $0.60, versus $0.30 reported last year. Revenue for the quarter came in at $522 million versus the consensus estimate of $1.89 billion.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

Earnings